12:00 AM
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Imetelstat: Completed Phase II enrollment

Geron completed enrollment of 116 patients who have not progressed after completing 4 cycles of platinum-based chemotherapy with or with Avastin bevacizumab in the open-label, U.S. Phase II B012 trial...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >